K562 cells were transfected with RanGAP1 shRNA and subsequently treated with 250 nM IM for 48 h to examine whether downregulation of the RanGAP1 protein level enhances drug efficacy in CML cells. Here, RANGAP1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.